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1.0  Introduction 
Tissue engineering has given opportunity to regenerate 
cartilage. Nowadays, cartilage tissue engineering can be 
merged with gene transfer approaches such as transient 
delivery of SOX9 gene using lipofection procedure (1). 
Optimization of this non-viral gene delivery procedure is 
necessary to identify optimum condition for efficient 
transfection in cell culture. Therefore, this study aims to 
optimize lipofection conditions for the delivery of SOX9 gene 
into human articular chondrocytes using various concentration 
of DNA. 
2.0  Materials and Methods 
With the approvals from the IIUM Research Ethics 
Committee (IREC), and National Medical Research Register 
(NMRR), human articular cartilage samples were obtained 
from consented patients after joint surgery. Chondrocytes 
were cultured and assigned to five different groups; positive 
control (C+), negative control (C-), 2 µg (D1), 4 µg (D2) and 
6 µg (D3) of pcDNA3-SOX9 expression vector. Freshly 
digested cells were used as normal control. Cells at passage 1 
(P1) were transfected with Lipofectamine 2000 (Invitrogen) 
according to manufacturer’s protocol. Transfected 
chondrocytes were expanded until passage 3 (P3). Expression 
of collagen type I, collagen type II, aggrecan, and SOX9 from 
each passage were evaluated by the two-step RT-PCR. The 
housekeeping genes, human glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) and β-actin were used as internal 
controls. 
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SOX9 is an essential transcription factor for chondrocyte differentiation and cartilage 
formation. The limited regenerative capacity of cartilage has led to the development of various 
treatment modality including gene transfer approaches. In this study, we transiently 
overexpressed or transfected SOX9 gene in articular chondrocytes derived from consented 
patients after joint surgery. The aim was to achieve optimum transfection effect by optimizing 
the lipofection procedure using various DNA concentrations. Chondrocytes were 
overexpressed with 2.0µg, 4.0µg and 6.0µg of pcDNA3-SOX9. The transfection effect on 
chondrocytes was assessed through the expression of collagen type II, aggrecan, SOX9 and 
collagen type I using the two-step reverse-transcriptase polymerase chain reaction (RT-PCR). 
Results showed that at low DNA concentration, the SOX9 transfection up-regulates all 
cartilage-specific markers expression, but down-regulates collagen type I. Hence, optimum 
transfection effect can be achieved using low DNA concentration. The ability to sustain the 
cartilage-specific markers indicates potential implications in cartilage engineering. 
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Fig. 1 Gel electrophoresis results following the two-step RT-PCR analysis of the mRNA expression of (A) β-actin, (B) GAPDH, (C) Collagen type I, (D) Aggrecan, 
(E) Collagen type II, (F) SOX9 for fresh digested sample, non-transfected chondrocytes, and transfected chondrocytes. Note: M (A,C,E) =1kb (1st Base DNA ladder), 
M (B,D,F) = 100bp DNA Ladder (GeneDirex),  [FD] = fresh digested samples [C+] = control positive i.e. cells transfected with no DNA, [C-] = control negative i.e. 
non-transfected cells, [D1] = cells transfected with DNA concentration 1 (2 µg), [D2] = cells transfected with DNA concentration 2 (4 µg), [D3]= cells transfected 
with DNA concentration 3 (6µg). 
2.0 Results 
 
Collagen type II expression was detectable in almost all 
groups throughout passages, with the most intense band 
showed in D2. Collagen type I was not expressed in D1 and 
D2 for P3 and was only expressed in D3. The increased band 
intensity for aggrecan in the transfected cells from P1 to P2 
demonstrated that 2 µg and 4 µg of DNA may be good 
enough for optimum transfection effect. Results are shown in 
Figure 1. 
4.0  Discussion and Conclusion 
Collagen type II and aggrecan expression in transfected cells 
with low DNA concentrations demonstrate efficient 
transfection and confirm the master role of SOX9 in 
chondrogenesis [1,2]. In this study, SOX9 overexpression 
suppressed collagen type I expression. It is a good indication 
since collagen type I often associated with dedifferentiation 
[3] and cartilage degeneration [4]. It can be concluded that 
optimum transfection efficiency can be achieved with low 
DNA concentrations and may have potential implications in 
cartilage tissue engineering. 
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